Scrip’s Five Must-Know Things – 28 September 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Novartis gives back Beigene PD-1; BMS revs R&D engine; Anthos changes course for Factor XI asset; the non-incretin pipeline for obesity; and a look at Q2’s top-selling drugs. https://scrip.citeline.com/SC149111/Quick-Listen-Scrips-Five-MustKnow-Things